4.1 Article

Diagnostic Criteria for Vascular Cognitive Disorders A VASCOG Statement

Journal

ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Volume 28, Issue 3, Pages 206-218

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WAD.0000000000000034

Keywords

vascular dementia; vascular cognitive disorder; vascular cognitive impairment; diagnostic criteria; cerebrovascular disease; multi-infarct dementia; poststroke dementia; subcortical dementia

Funding

  1. National Health and Medical Research Council of Australia [568940, 568969, 401, 162]
  2. Australian Research Council [DP120102078]
  3. Pfizer
  4. Eli Lilly
  5. Alzheimer's Research UK
  6. Medical Research Council
  7. Dunhill Medical Trust, UK
  8. Mitsubishi Tanabe Pharma, Japan
  9. Roche
  10. Elan
  11. GlaxoSmithKline
  12. Novartis
  13. Bristol-Myers Squibb
  14. Lundbeck
  15. Brain Canada
  16. Alzhiemer's Drug discovery Foundation
  17. Canadian Institutes of Health Research
  18. Canada Foundation for Innovation
  19. Canadian Stroke Network
  20. Heart and Stroke Foundation of Canada
  21. National Institutes of Health
  22. NIH
  23. Brill Chair in Neurology, Department of Medicine, Sunnybrook Health Sciences Centre
  24. University of Toronto
  25. Sunnybrook Research Institute
  26. Alzheimer's Association
  27. anonymous foundation
  28. Merck
  29. GSK
  30. National Research Foundation [NRF-CRP 3-2008-01]
  31. National Medical Research Council [NMRC/xxxx/2011, NMRC/1288/2011]
  32. Ministere de l'Enseignement Superieur et de la Recherche
  33. Direction Generale de l'Offre de Soins (Ministry of Health)
  34. Alzheimer Center VUmc
  35. Brain Foundation of the Netherlands [H07.03]
  36. Alzheimer Nederland [WE.03-2012-02]
  37. Canadian Institutes of Health Research [MOP-209888]
  38. Nova Scotia Health Research Foundation [MED2006-2086]
  39. Alzheimer Society of Canada
  40. Dalhousie Medical Research Foundation
  41. Canadian Institutes of Health Research: the Canadian Dementia Knowledge Translation Network [200711DIP]
  42. National Natural Science Foundation of China: The Canada China Joint Health Research Initiative, Quantification of health status changes in China and in Canada [CCI92216]
  43. Alzheimer Society of Canada [10_67]
  44. VUmc Fonds
  45. MRC [G0900652, G0500247, MR/L016451/1, G1100540, G0400074, G0502157] Funding Source: UKRI
  46. Medical Research Council [G0700718B, G0400074, G0900652, MR/L016451/1, G1100540, G0502157, G0500247] Funding Source: researchfish
  47. NIHR Newcastle Biomedical Research Centre [BH111030] Funding Source: researchfish

Ask authors/readers for more resources

Background: Several sets of diagnostic criteria have been published for vascular dementia since the 1960s. The continuing ambiguity in vascular dementia definition warrants a critical reexamination. Methods: Participants at a special symposium of the International Society for Vascular Behavioral and Cognitive Disorders (VASCOG) in 2009 critiqued the current criteria. They drafted a proposal for a new set of criteria, later reviewed through multiple drafts by the group, including additional experts and the members of the Neurocognitive Disorders Work Group of the fifth revision of Diagnostic and Statistical Manual (DSM-5) Task Force. Results: Cognitive disorders of vascular etiology are a heterogeneous group of disorders with diverse pathologies and clinical manifestations, discussed broadly under the rubric of vascular cognitive disorders (VCD). The continuum of vascular cognitive impairment is recognized by the categories of Mild Vascular Cognitive Disorder, and Vascular Dementia or Major Vascular Cognitive Disorder. Diagnostic thresholds are defined. Clinical and neuroimaging criteria are proposed for establishing vascular etiology. Subtypes of VCD are described, and the frequent cooccurrence of Alzheimer disease pathology emphasized. Conclusions: The proposed criteria for VCD provide a coherent approach to the diagnosis of this diverse group of disorders, with a view to stimulating clinical and pathologic validation studies. These criteria can be harmonized with the DSM-5 criteria such that an international consensus on the criteria for VCD may be achieved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available